CD44 and breast cancer: CD44+/CD24-/low CSCs, derived from breast cancer, exhibit migration potential that increases with tumor grade [13], while a human CD44+ CD24-/low Lin- and mouse Thy1+ CD24+ Lin- CSC-enriched population exhibits low ROS levels and high expression of anti-ROS genes [14].